Skip Navigation

Neuro-Oncology 2006 8(2):127-136; doi:10.1215/15228517-2005-013
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Brandsma, D.
Right arrow Articles by Voest, E. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Brandsma, D.
Right arrow Articles by Voest, E. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 by the Society for Neuro-Oncology

Constitutive integrin activation on tumor cells contributes to progression of leptomeningeal metastases1

Dieta Brandsma23, Laurien Ulfman3, Jaap C. Reijneveld3, Madelon Bracke, Martin J.B. Taphoorn, Jaap Jan Zwaginga, Martijn F.B. Gebbink, Hetty de Boer, Leo Koenderman and Emile E. Voest

Departments of Medical Oncology (D.B., J.C.R., M.J.B.T., E.E.V.), Neurology (D.B., J.C.R., M.J.B.T.), Pulmonary Diseases (L.U., L.K.), and Haematology (M.F.B.G.), University Medical Center Utrecht, Utrecht; and Department of Pharmaco-epidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, University Medical Center Utrecht, Utrecht (M.B.); Department of Haematology, Academic Medical Center, University of Amsterdam, Amsterdam (J.J.Z.); Sanquin Research, Amsterdam (J.J.Z.); and Department of Nephrology, Leiden University Medical Center, Leiden (H.D.); The Netherlands

2 Address correspondence to Dieta Brandsma, Department of Neurology, University Medical Center Utrecht, P.O. Box 85500, 3584 CX Utrecht, The Netherlands (d.brandsma{at}umcutrecht.nl).


   Abstract

Leptomeningeal metastases are a serious neurological complication in cancer patients and associated with a dismal prognosis. Tumor cells that enter the subarachnoid space adhere to the leptomeninges and form tumor deposits. It is largely unknown which adhesion molecules mediate tumor cell adhesion to leptomeninges. We studied the role of integrin expression and activation in the progression of leptomeningeal metastases. For this study, we used a mouse acute lymphocytic leukemic cell line that was grown in suspension (L1210-S cell line) to develop an adherent L1210 cell line (L1210-A) by selectively culturing the few adherent cells in the cell culture. β1, β2, and β3 integrins were in a constitutively high active state on L1210-A cells and in a low, but inducible, active state on L1210-S cells. Expression levels of these integrins were comparable in the two cell lines. Static adhesion levels of L1210-A cells on a leptomeningeal cell layer were significantly higher than those of L1210-S cells. All mice that were injected intrathecally with L1210-A cells died rapidly of leptomeningeal leukemia. In contrast, 45% long-term survival was seen after intrathecal injection of mice with L1210-S cells. Our data indicate that constitutive integrin activation on leukemic cells promotes progression of leptomeningeal leukemia by increased tumor cell adhesion to the leptomeninges. We argue that an aberrantly regulated inside-out signaling pathway underlies constitutive integrin activation on the adherent leukemic cell population.

Keywords: adhesion, integrin activation, L1210, leptomeningeal metastases, mouse

Received July 15, 2005; Accepted December 19, 2005


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Neuro OncologyHome page
Y. Piao, L. Lu, and J. de Groot
AMPA receptors promote perivascular glioma invasion via {beta}1 integrin-dependent adhesion to the extracellular matrix
Neuro Oncology, June 1, 2009; 11(3): 260 - 273.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.